Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

166 Results
Title Activity Code Posting Date Expiration Date Sort ascending
Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival- NOT-AI-22-023 R21, R01 February 23, 2022 May 08, 2026
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement, Clinical Trial Optional)- PA-20-135 Supp March 10, 2020 September 08, 2025
Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection- NOT-HL-22-004 R01, R21 December 21, 2021 September 08, 2025
Notice of Special Interest (NOSI)—Opportunities for HIV Cure Interventions at the Time of ART Initiation- NOT-AI-22-056 R01, R21 August 05, 2022 September 08, 2025
Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-22-012 Multiple July 11, 2022 August 08, 2025
Notice of Special Interest (NOSI)— Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP) - NOT-AI-22-042 R01 April 29, 2022 May 08, 2025
Notice of Special Interest (NOSI)—Towards Developing a Cure for HBV in HIV/HBV Co-Infection - NOT-AI-22-043 R01, R41/R42, R21, R43/R44 April 29, 2022 May 08, 2025
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-22-105 R01 May 10, 2022 May 08, 2025
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-22-109 R21 May 10, 2022 May 08, 2025
Notice of Special Interest (NOSI)— Climate Change and Health- NOT-ES-22-006 Multiple June 01, 2022 May 08, 2025
Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)- PAR-22-185 X01 May 27, 2022 January 18, 2025
Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)- RFA-HL-23-007 K38 March 14, 2022 January 11, 2025
Notice of Special Interest (NOSI)—Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes- NOT-AI-21-080 R21, R01 October 18, 2021 January 08, 2025
Notice of Special Interest (NOSI)—Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity- NOT-AI-21-072 R21 October 20, 2021 January 08, 2025
Notice of Special Interest (NOSI)—Accelerating Progress in Celiac Disease Research- NOT-AI-22-004 Multiple November 23, 2021 January 08, 2025
Notice of Special Interest (NOSI)—Molecular and Genetic Characterization of Inborn Errors of Immunity- NOT-AI-21-082 R01, R21 November 29, 2021 January 08, 2025
Notice of Special Interest (NOSI)—Accelerating Malaria Vaccine Discovery- NOT-AI-22-014 R01 December 01, 2021 January 08, 2025
Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine- NOT-AI-22-013 R01, R21 December 13, 2021 January 08, 2025
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-22-060 R15 January 10, 2022 January 08, 2025
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)- PAR-22-075 K22 January 20, 2022 January 08, 2025
Transgender People—Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)- PAR-22-186 R21 May 19, 2022 December 08, 2024
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)- PAR-22-222 R01 August 04, 2022 December 08, 2024
Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)- PAR-22-223 R01 August 09, 2022 December 08, 2024
Chemical Countermeasures Research Program (CCRP) Initiative—Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)- RFA-DA-23-056 R01 August 17, 2022 November 20, 2024
Notice of Special Interest (NOSI)—Administrative Supplements for Research on Womens Health in the IDeA States- NOT-GM-22-005 Supp April 06, 2022 October 18, 2024